Showing results (141-150 of 1,103) with videos related to

Sort By:
Pageof 111
JBMR Plus|September 29, 2025
Increased lifelong burden of comorbidities without increased early mortality in hereditary hypophosphatemia: a Danish register studySigne Sparre Beck-Nielsen, Rikke Færgemann Hansen, Ulla Ege Johansen, et al.
JBMR Plus|September 24, 2025
Romosozumab in postmenopausal women with smoldering multiple myeloma: a prospective 12-mo studyMariana Diz Lopes, Francesco Pollastri, Francesca Mastropaolo, et al.
JBMR Plus|September 22, 2025
Impact of upacicalcet on bone metabolism in hemodialysis patients with secondary hyperparathyroidism: a post-hoc analysisSuguru Yamamoto, Shinji Yoneda, Hisami Yasuzawa, et al.
JBMR Plus|September 22, 2025
G protein-coupled receptor 35 stimulation reduces osteoclast activity in primary human bone cellsMaria L Price, Rachael A Wyatt, Ana Crastin, et al.
JBMR Plus|September 22, 2025
Sulfate biology genes are associated with mineralization in mouse and humanKun-Di Lee, Paul A Dawson, Kim M Summers
JBMR Plus|September 22, 2025
Urinary calcium and bone resorption markers during 3 years of denosumab treatment in pediatric osteogenesis imperfectaStefanie Stasek, Susanna Reincke, Mirko Rehberg, et al.
JBMR Plus|August 13, 2025
The mineralization of osteonal cement line depends on where the osteon is formedAstrid Cantamessa, Stéphane Blouin, Maximilian Rummler, et al.
JBMR Plus|August 4, 2025
Ectopic pseudojoints in fibrodysplasia ossificans progressivaRobert J Pignolo, Mona Al Mukaddam, Stephen Broski, et al.
JBMR Plus|September 10, 2025
Osteonecrosis of the external auditory canal in two patients on denosumab therapyHolly Wang, Matthew Yii, Bing Mei Teh, et al.
JBMR Plus|September 22, 2025
Sodium-glucose co-transporter-2 inhibitors vs metformin in reducing osteoarthritis risk: a retrospective cohort study of health insurance claims and check-up dataMasaki Hatano, Yusuke Sasabuchi, Akira Okada, et al.
Pageof 111